These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8450239)

  • 1. A sensitive method to detect defined peptide among those eluted from murine MHC class II molecules.
    Brumeanu TD; Kohanski R; Bona CA; Zaghouani H
    J Immunol Methods; 1993 Mar; 160(1):65-71. PubMed ID: 8450239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of the binding of MHC class II-derived peptides to MHC class II.
    Feili-Hariri M; Kao H; Mietzner TA; Morel PA
    Int Immunol; 1996 Dec; 8(12):1857-65. PubMed ID: 8982770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatically mediated, glycosidic conjugation of immunoglobulins with viral epitopes.
    Brumeanu TD; Dehazya P; Wolf I; Bona CA
    J Immunol Methods; 1995 Jun; 183(2):185-97. PubMed ID: 7541431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.
    Burt DS; Mills KH; Skehel JJ; Thomas DB
    J Exp Med; 1989 Aug; 170(2):383-97. PubMed ID: 2474053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.
    Nag B; Mukku PV; Arimilli S; Kendrick T; Deshpande SV; Sharma SD
    J Immunol Methods; 1994 Mar; 169(2):273-85. PubMed ID: 7510762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule.
    Mills KH; Burt DS; Skehel JJ; Thomas DB
    J Immunol; 1988 Jun; 140(12):4083-90. PubMed ID: 2453566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.
    Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB
    J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
    Casares S; Zong CS; Radu DL; Miller A; Bona CA; Brumeanu TD
    J Exp Med; 1999 Aug; 190(4):543-53. PubMed ID: 10449525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of changes at peptide residues contacting MHC class II T-cell receptor on antigen recognition and human Th0 cell effector function.
    Lamb JR; Higgins JA; Hetzel C; Hayball JD; Lake RA; O'Hehir RE
    Immunology; 1995 Jul; 85(3):447-54. PubMed ID: 7558134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-mediated modulation of T-cell allorecognition.
    Eckels DD; Gorski J; Rothbard J; Lamb JR
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8191-5. PubMed ID: 2973061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice.
    Shih FF; Cerasoli DM; Caton AJ
    Int Immunol; 1997 Feb; 9(2):249-61. PubMed ID: 9040007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus.
    Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA; Zaghouani H
    J Exp Med; 1993 Nov; 178(5):1795-9. PubMed ID: 8228825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering and characterization of a murine MHC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope.
    Casares S; Bona CA; Brumeanu TD
    Protein Eng; 1997 Nov; 10(11):1295-301. PubMed ID: 9514118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.